Brooklyn Center, MN, United States of America

Celeste Ondich



 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Celeste Ondich: Innovator in Pharmaceutical Compositions

Introduction

Celeste Ondich is a notable inventor based in Brooklyn Center, MN (US). She has made significant contributions to the field of pharmaceutical compositions, holding a total of 2 patents. Her work focuses on innovative solutions that enhance the efficacy of drug delivery systems.

Latest Patents

Celeste's latest patents involve the development of pharmaceutical compositions that utilize substantially spherical microspheres. These microspheres comprise at least one active pharmaceutical ingredient (API) that is substantially dispersed in a polymer, along with a lyoprotectant on the outer surface. The microspheres are designed to have a D99 particle diameter of less than about 10 µm and a D90 circularity value ranging from about 0.8 to about 1.0. These compositions are intended for injectable applications, providing methods for treating various medical conditions through the administration of these innovative formulations.

Career Highlights

Celeste Ondich has established herself as a key figure in her field, contributing to advancements in pharmaceutical technology. Her work at Spinethera has been instrumental in developing new methods for drug delivery, showcasing her commitment to improving patient outcomes through innovative solutions.

Collaborations

Celeste collaborates with talented professionals in her field, including Jeffrey Missling and Emily R Rolfes Meyering. These partnerships enhance the research and development efforts at Spinethera, fostering an environment of innovation and creativity.

Conclusion

Celeste Ondich's contributions to pharmaceutical compositions exemplify her dedication to innovation in the medical field. Her patents reflect a commitment to advancing drug delivery systems, ultimately benefiting patients and healthcare providers alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…